Additive-Controlled Stereoselective Glycosylations of Oxazolidinone-Protected Glucosamine and Galactosamine Thioglycoside Donors Based on Preactivation Protocol

Abstract

Based on a pre-activation protocol, the stereoselectivity of oxazolidinone-protected amino sugar thioglycoside donors towards glycosylations can be controlled by additives. Either α- or β-selectivity could be obtained by changing additives. 2,4,6-Tri-tert-butylpyrimidine (TTBP) was the best β-directing additive, while thiophene worked as the best α-directing additive. The bifunctional additives such as tetrabutyl ammonium iodide (TBAI) afforded either α- or β-selectivity depending on the amount added. Poor α-­selectivity of some glycosylations without any additives was greatly improved by adding TBAI or thiophene.

glycosylation - stereoselectivity - preactivation - additive - carbohydrate

References and Notes

<A NAME="RW08710ST-1">1</A> Boltje TJ. Buskas T. Boons GJ. Nat. Chem.  2009,  1:  611 

<A NAME="RW08710ST-2">2</A> Zhu XM. Schmidt RR. Angew. Chem. Int. Ed.  2009,  48:  1900 

<A NAME="RW08710ST-3">3</A> Demchenko AV. Synlett  2003,  1225 

<A NAME="RW08710ST-4A">4a</A> Benakli K. Zha C. Kerns RJ. J. Am. Chem. Soc.  2001,  123:  9461 

<A NAME="RW08710ST-4B">4b</A> Boysen M. Gemma E. Lahmann M. Oscarson S. Chem. Commun.  2005,  3044 

<A NAME="RW08710ST-4C">4c</A> Manabe S. Ishii K. Ito Y. J. Am. Chem. Soc.  2006,  128:  10666 

<A NAME="RW08710ST-4D">4d</A> Geng Y. Zhang L.-H. Ye X.-S. Chem. Commun.  2008,  597 

<A NAME="RW08710ST-5A">5a</A> van der Plas HC. Koudijs A. Recl. Trav. Chim. Pays-Bas  1978,  97:  159 

<A NAME="RW08710ST-5B">5b</A> Crich D. Smith M. Yao Q. Picione J. Synthesis  2001,  323 

<A NAME="RW08710ST-6A">6a</A> Huang X. Huang L. Wang H. Ye X.-S. Angew. Chem. Int. Ed.  2004,  43:  5221 

<A NAME="RW08710ST-6B">6b</A> Huang L. Wang Z. Li X. Ye X.-S. Huang X. Carbohydr. Res.  2006,  341:  1669 

<A NAME="RW08710ST-6C">6c</A> Huang L. Huang X. Chem. Eur. J.  2007,  13:  529 

<A NAME="RW08710ST-6D">6d</A> Wang Y. Ye X.-S. Zhang L.-H. Org. Biomol. Chem.  2007,  5:  2189 

<A NAME="RW08710ST-7A">7a</A> Crich D. Sun S. J. Org. Chem.  1996,  61:  4506 

<A NAME="RW08710ST-7B">7b</A> Crich D. Sun S. J. Org. Chem.  1997,  62:  1198 

<A NAME="RW08710ST-7C">7c</A> Codée JDC. Van den Bos LJ. Litjens REJN. Overkleeft HS. Van Boom JH. Van der Marel GA. Org. Lett.  2003,  5:  1947 

<A NAME="RW08710ST-7D">7d</A> Yamago S. Yamada T. Maruyama T. Yoshida J.-I. Angew. Chem. Int. Ed.  2004,  43:  2145 

<A NAME="RW08710ST-7E">7e</A> Nguyen HM. Poole JL. Gin DY. Angew. Chem. Int. Ed.  2001,  40:  414 

<A NAME="RW08710ST-8A">8a</A> Wei P. Kerns RJ. J. Org. Chem.  2005,  70:  4195 

<A NAME="RW08710ST-8B">8b</A> Olsson JD. Eriksson L. Lahmann M. Oscarson S.
J. Org. Chem.  2008,  73:  7181 

<A NAME="RW08710ST-8C">8c</A> Manabe S. Ishii K. Hashizume D. Koshino H. Ito Y. Chem. Eur. J.  2009,  15:  6894 

<A NAME="RW08710ST-9">9</A> Wang C. Wang H. Huang X. Zhang L.-H. Ye X.-S. Synlett  2006,  2846 

<A NAME="RW08710ST-10A">10a</A> Crich D. Sun S. J. Am. Chem. Soc.  1997,  119:  11217 

<A NAME="RW08710ST-10B">10b</A> Crich D. Cai W. J. Org. Chem.  1999,  64:  4926 

<A NAME="RW08710ST-10C">10c</A> Crich D. Smith M. J. Am. Chem. Soc.  2001,  123:  9015 

Although participating solvents such as Et₂O or MeCN can influence the intermediate of glycosylations, they cannot be used as additives because a large excess of them are needed. About the solvent effect, see:

<A NAME="RW08710ST-11A">11a</A> Wulff G. Rohle G. Angew. Chem., Int. Ed. Engl.  1974,  13:  157 

<A NAME="RW08710ST-11B">11b</A> Vankar D. Vankar PS. Behrendt M. Schmidt RR. Tetrahedron  1992,  47:  9985 ; and references cited therein

<A NAME="RW08710ST-12">12</A> Mukaiyama T. Angew. Chem. Int. Ed.  2004,  43:  5590 ; and references cited therein

<A NAME="RW08710ST-13">13</A> Lemieux RU. Hendriks KB. Stick RV. James K.
J. Am. Chem. Soc.  1975,  97:  4056 ; and references cited therein

<A NAME="RW08710ST-14">14</A> Park J. Kawatkar S. Kim JH. Boons GJ. Org. Lett.  2007,  9:  1959 

Sulfonium ion observation:

<A NAME="RW08710ST-15A">15a</A> West AC. Schuerch C. J. Am. Chem. Soc.  1973,  95:  1333 

<A NAME="RW08710ST-15B">15b</A> Kim JH. Yang H. Park J. Boons GJ. J. Am. Chem. Soc.  2005,  127:  12090 

<A NAME="RW08710ST-15C">15c</A> Nokami T. Shibuya A. Manabe S. Ito Y. Yoshida J. Chem. Eur. J.  2009,  15:  2252 

<A NAME="RW08710ST-16">16</A> Hadd MJ. Gervay J. Carbohydr. Res.  1999,  320:  61 

<A NAME="RW08710ST-17">17</A>

General Procedures for Glycosylations of Donors 1 or 2 with Acceptors 3-8
Tf₂O (8.7 µL, 0.052 mmol, 1.3 equiv) was added to a stirred mixture of donors 1 or 2 (21.2 mg, 0.048 mmol, 1.2 equiv), BSM (11.1 mg, 0.052 mmol, 1.3 equiv), and activated 4 Å MS (300 mg, powder) in CH₂Cl₂ (3 mL) at -73 ˚C under nitrogen atmosphere. The reaction mixture was stirred for 5 min, after loss of the donor detected by TLC, the additive (0.1-2.0 equiv) was added to the mixture. After stirring for 15 min, a solution of the acceptor 3 (15.0 mg, 0.040 mmol, 1.0 equiv) or other acceptors in CH₂Cl₂ (0.2 mL) was added dropwise to the reaction mixture. The mixture was stirred and warmed up to r.t. slowly, quenched by Et₃N (0.1 mL). The precipitate was filtered off, and the filtrate was concentrated. The residue was purified by column chromatography on silica gel to give the products.

<A NAME="RW08710ST-18">18</A>

Representative Procedures for Detecting Intermediates after Activation of Donor 1 by Variable Temperature NMR Spectroscopy
To a solution of donor 1 (8.7 mg, 0.02 mmol), BSM (5.1 mg, 0.024 mmol) in CD₂Cl₂ (0.5 mL) in a NMR tube at -60 ˚C, under an argon atmosphere, was added 1.2 equiv of Tf₂O (0.024 mmol, 4.1 µL). The NMR tube was immediately transferred to the pre-cooled NMR probe (-60 ˚C), and ^¹H NMR was recorded. Subsequently the temperature of the probe was raised in 10 ˚C steps with monitoring by ^¹H NMR.

<A NAME="RW08710ST-19">19</A>

Product 9 was purified by column chromatography on silica gel (PE-EtOAc, 3:1); R _f  = 0.3 (PE-EtOAc, 1.5:1). ^¹H NMR (400 MHz, CDCl₃): δ = 7.59-7.61 (m, 2 H), 7.33-7.40 (m, 8 H), 6.25 (d, 1 H, J = 2.8 Hz, H-1′), 5.55 (s, 1 H), 5.30 (s, 1 H), 4.70 (d, 1 H, J = 3.6 Hz, H-1), 4.64 (d, 1 H, J = 11.6 Hz), 4.53 (d, 1 H, J = 11.6 Hz), 4.11-4.34 (m, 6 H), 3.77-3.84 (m, 2 H), 3.72 (t, 1 H, J = 10.0 Hz), 3.51-3.56 (m, 2 H), 3.37 (s, 3 H), 2.40 (s, 3 H), 2.08 (s, 3 H), 2.04 (s, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 170.38 (2 C), 169.35, 152.90, 137.54, 137.11, 128.80, 128.62, 128.54, 128.47, 128.05, 126.29, 126.20, 101.14, 97.94, 95.01, 82.39, 78.38, 72.98, 72.07, 72.00, 68.87, 68.03, 65.80, 61.77, 61.54, 56.06, 55.17, 23.80, 20.58, 20.54. ESI-MS: m/z = 686 [M + H]⁺, 703 [M + NH₄]⁺, 708 [M + Na]⁺. Anal. Calcd for C₃₄H₃₉NO₁₄: C, 59.56; H, 5.73; N, 2.04. Found: C, 59.30; H, 5.69; N, 1.97.

<A NAME="RW08710ST-20">20</A>

Product 10 was purified by column chromatography on silica gel (PE-EtOAc, 1.5:1); R _f  = 0.1 (PE-EtOAc, 1.5:1). ^¹H NMR (400 MHz, CDCl₃): δ = 7.48-7.50 (m, 2 H), 7.31-7.38 (m, 8 H), 5.59 (s, 1 H), 5.56 (s, 1 H), 5.08 (d, 1 H, J = 7.6 Hz, H-1′), 4.64 (d, 1 H, J = 11.8 Hz), 4.54 (d, 1 H, J = 3.6 Hz, H-1), 4.52 (d, 1 H, J = 12.0 Hz), 4.32 (dd, 1 H, J = 7.6, 12.0 Hz), 4.15-4.24 (m, 3 H), 3.95-4.08 (m, 3 H), 3.63-3.79 (m, 4 H), 3.30 (s, 3 H), 2.38 (s, 3 H), 2.10 (s, 3 H), 1.98 (s, 3 H). ^¹³C NMR (100 MHz, CDCl₃): δ = 171.25, 170.28, 169.33, 153.54, 137.91, 137.35, 128.86, 128.56, 128.18, 128.03, 127.45, 126.04, 103.01, 100.85, 98.25, 80.63, 78.79, 77.23, 76.33, 72.98, 72.23, 68.84, 64.06, 62.53, 61.33, 57.55, 55.22, 25.08, 20.59, 20.56. ESI-MS:
m/z = 686 [M + H]⁺, 703 [M + NH₄]⁺, 708 [M + Na]⁺, 724 [M + K]⁺. Anal. Calcd for C₃₄H₃₉NO₁₄: C, 59.56; H, 5.73; N, 2.04. Found: C, 59.34; H, 5.67; N, 1.96.

<A NAME="RW08710ST-21">21</A>

The α-anomers and β-anomers were identified by their ^¹H NMR coupling constants for anomeric protons. For α-anomers, J _1,2 = 2.4-2.8 Hz; for β-anomers, J _1,2 = 7.2-7.6 Hz.